These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 10324121

  • 1. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan 02; 46(1):28-30. PubMed ID: 10324121
    [Abstract] [Full Text] [Related]

  • 2. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep 12; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [Abstract] [Full Text] [Related]

  • 3. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
    Fed Regist; 1982 Sep 07; 47(173):39249-50. PubMed ID: 10258155
    [Abstract] [Full Text] [Related]

  • 4. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep 07; 47(173):39147-55. PubMed ID: 10258154
    [Abstract] [Full Text] [Related]

  • 5. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan 02; 46(1):28. PubMed ID: 10249520
    [Abstract] [Full Text] [Related]

  • 6. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2006 Jan 24; 71(15):3921-97. PubMed ID: 16479698
    [Abstract] [Full Text] [Related]

  • 7. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT, Barash PG.
    Anesth Analg; 2009 Jan 24; 108(1):211-8. PubMed ID: 19095852
    [Abstract] [Full Text] [Related]

  • 8. Revisions to the general safety requirements for biological products--FD. Direct final rule.
    Fed Regist; 1998 Apr 20; 63(75):19399-403. PubMed ID: 10178869
    [Abstract] [Full Text] [Related]

  • 9. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 11; 68(238):69009-20. PubMed ID: 14672084
    [Abstract] [Full Text] [Related]

  • 10. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan 03; 65(1):7-9. PubMed ID: 11010625
    [Abstract] [Full Text] [Related]

  • 11. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Nov 30; 72(230):67639-40. PubMed ID: 18064767
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec 03; 64(232):67720-63. PubMed ID: 11010665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Nov 29; 69(228):69278-80. PubMed ID: 15570675
    [Abstract] [Full Text] [Related]

  • 16. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec 14; 63(239):68676-8. PubMed ID: 10187558
    [Abstract] [Full Text] [Related]

  • 17. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May 14; 64(93):26282-7. PubMed ID: 10558530
    [Abstract] [Full Text] [Related]

  • 18. Labeling requirements for systemic antibacterial drug products intended for human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Feb 06; 68(25):6062-81. PubMed ID: 12577966
    [Abstract] [Full Text] [Related]

  • 19. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug 03; 58(147):41348-54. PubMed ID: 10127711
    [Abstract] [Full Text] [Related]

  • 20. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 13; 68(114):35290-3. PubMed ID: 12807133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.